賈躍曉，理學博士，常州大學醫學與健康工程學院講師（2022年至今）。2013年獲華東理工大學材料科學與工程學院工學學士學位，2018年獲中國科學院國家納米科學中心理學博士學位，導師為蔣興宇教授。2018年至2022年在南方科技大學生物醫學工程系從事博士後研究，研究方向包括納米生物醫學、抗菌醫用材料及分析化學。
主持中國博士後科學基金面上資助項目（2020-2022），參與國家自然科學基金國際合作與交流項目（2017-2020）、中國科學院前沿科學重點研究計畫項目（2016-2020）。2024年獲批國家自然科學基金青年基金項目。在《Cell Host & Microbe》《Chemical Communications》《Analytical Chemistry》等期刊發表論文21篇，其中以第一作者或共同第一作者身份發表12篇，研究內容涵蓋金納米顆粒抗菌性能調控、多臂抗生素分子設計等。作為共同發明人獲授權發明專利4項，涉及納米晶纖維素檢測技術及多臂分子抗菌藥物開發。
基本介紹
- 中文名：賈躍曉
- 學位/學歷：博士
- 主要成就：常州大學醫學與健康工程學院講師
- 畢業院校：華東理工大學 、中國科學院
- 專業方向：納米生物醫學
個人經歷,主要科研項目,代表性論文,代表性專利,
個人經歷
2022–：常州大學，醫學與健康工程學院，講師
2018–2022：南方科技大學，生物醫學工程系，博士後（導師：蔣興宇教授）
2009–2013：華東理工大學，材料科學與工程學院，工學學士
主要科研項目
[1] 中國博士後科學基金面上資助，2020-2022，結題，主持
[2] 國家自然科學基金委國際(地區)合作與交流項目，2017-2020，結題，參與
[3] 中國科學院前沿科學重點研究計畫項目，2016-2020，結題，參與
代表性論文
[1] Yuexiao Jia, Wenwen Chen, Rongbing Tang, Jiangjiang Zhang, Xiaoyan Liu, Ruihua Dong, Fupin Hu, Xingyu Jiang*, Multi-armed antibiotics for Gram-positive bacteria. Cell Host & Microbe, 2023, 31, 1101–1110. (IF: 31.316)
[2] Yuexiao Jia, Jiangjiang Zhang, Yingcan Zhao, Ruihua Dong, Huiwang Wang, Xingyu Jiang*, Gold Nanoparticles Bearing a Clinically Used None-antibiotic Drug for Combating Multi-drug Resistant Bacteria. Chemical Communications, 2022, 58, 10544–10547. (IF: 6.222)
[3] Yuexiao Jia, Wenshu Zheng, Xiaohui Zhao, Jiangjiang Zhang, Wenwen Chen, Xingyu Jiang*, Mixing-to-answer iodide sensing with commercial chemicals. Analytical Chemistry, 2018, 90, 8276–8282. (IF: 6.986)
[4] Yuexiao Jia, Yongming Guo, Shiwen Wang, Wenwen Chen, Jiangjiang Zhang, Wenshu Zheng, Xingyu Jiang*, Nanocrystalline cellulose mediated seed-growth for ultra-robust colorimetric detection of hydrogen sulfide. Nanoscale, 2017, 9, 9811–9817. (IF: 7.790)
[5] Ruihua Dong, Mian Chen, Yuexiao Jia (co-first author), Hao Tang, Ziyin Xiong, Yunze Long, Xingyu Jiang*, An in situ dressing material containing a multi-armed antibioticfor healing irregular wounds. Aggregate, 2024, e493. (IF: 18.8)
[6] Yingcan Zhao, Yuexiao Jia (co-first author), Jiayi Xu, Liang Han, Feng He, Xingyu Jiang*, The antibacterial activities of MoS2 nanosheets towards multi-drug resistant bacteria. Chemical Communications, 2021, 57, 2998–3001. (IF: 6.222)
[7] Xiaohui Zhao, Yuexiao Jia (co-first author), Ruihua Dong, Jinqi Deng, Hao Tang, Fuping Hu, Shaoqin Liu, Xingyu Jiang*, Bimetallic nanoparticles against multi-drug resistant bacteria. Chemical Communications, 2020, 56, 10918–10921. (IF: 6.222)
[8] Xiaohui Zhao, Yuexiao Jia (co-first author), Juanjuan Li, Ruihua Dong, Jiangjiang Zhang, Chuanxin Ma, Hui Wang, Yukui Rui, Xingyu Jiang*, Indole derivatives-capped gold nanoparticles as effective bactericide in vivo. ACS Applied Materials & Interfaces, 2018, 10, 29398–29406. (IF: 9.229)
[9] Wenshu Zheng, Yuexiao Jia, Xingyu Jiang*, et al. Reversing bacterial resistance to gold nanoparticles by size modulation, Nano Letters, 2021, 21, 1992–2000. (IF: 11.189)
[10] Xiaoyan Liu, Yuexiao Jia, Xingyu Jiang*, et al. Integrating a concentration gradient generator and a single-cell trapper array for high-throughput screening the bioeffects of nanomaterials, Angewandte Chemie International Edition, 2021, 60, 12319–12322. (IF: 15.336)
[11] Jiangjiang Zhang, Yuexiao Jia, Xingyu Jiang*, et al. Four-in-One: Advanced copper nanocomposites for multianalyte assays and multicoding logic gates, ACS Nano, 2020, 14, 9107–9116. (IF: 15.881)
[12] Rongbing Tang, Yuexiao Jia, Xingyu Jiang*, et al. Nano-catalyst complex can dephosphorylate key proteins in MAPK Pathway for Cancer Therapy. Advanced Healthcare Materials,2018, 7, 1800533. (IF: 9.933)
[13] Wenshu Zheng, Yuexiao Jia, Xingyu Jiang*, et al. Universal coating from electrostatic self-assembly to prevent multidrug-resistant bacterial colonization on medical devices and solid surfaces. ACS Applied Materials & Interfaces, 2017, 9, 21181−21189. (IF: 9.229)
[14] Ruihua Dong, Yuexiao Jia, Xingyu Jiang* and Yunze Long, et al. In situ deposition of a personalized nanofibrous dressing via a handy electrospinning device for skin wound care. Nanoscale, 2016, 8, 3482–3488. (IF: 7.790)
[15] Wenwen Chen, Yuexiao Jia, Xingyu Jiang*, et al. Colorimetric detection of Al(III) in vermicelli samples based on ionic liquid group coated gold nanoparticles. RSC Advances, 2015, 5, 62260–62264. (IF: 3.361)
[16] Zeyang Pang, Qizhen Li, Yuexiao Jia, Xingyu Jiang*, et al. Controlling pyridinium-zwitterionic ligand ratio on atomically precise gold nanoclusters allowing for eradicating Gram-positive drug-resistant bacteria and retaining biocompatibility. Chemical science, 2021, 12, 14871–14882. (IF: 9.825)
[17] Yan Feng, Wenwen Chen, Yuexiao Jia, Xingyu Jiang*, et al. N-heterocyclic molecule-capped gold nanoparticles as effective antibiotics against multi-drug resistant bacteria. Nanoscale, 2016, 8, 13223–13227. (IF: 7.790)
[18] Shiwen Wang, Jiashu Sun, Yuexiao Jia, Xingyu Jiang*, et al. Nanocrystalline cellulose-assisted generation of silver nanoparticles for nonenzymatic glucose detection and antibacterial agent. Biomacromolecules, 2016, 17, 2472−2478. (IF: 6.988)
[19] Ying Li, Zheng Zhao, Jiangjiang Zhang, Ryan T. K. Kwok, Sheng Xie, Rongbing Tang, Yuexiao Jia, Xingyu Jiang*, Benzhong Tang，et al. A bifunctional aggregation-induced emission luminogen for monitoring and killing of multidrug-resistant bacteria. Advanced Functional Materials, 2018, 1804632. (IF: 18.808)
[20] Xinglong Yang, Junchuan Yang, Le Wang, Bei Ran, Yuexiao Jia, Xingyu Jiang*, et al. Pharmaceutical intermediate-modified gold nanoparticles: against multidrug-resistant bacteria and wound-healing application via an electrospun scaffold. ACS Nano, 2017, 11, 5737−5745. (IF: 15.881)
[21] Ying Li, Yue Tian, Wenshu Zheng, Yan Feng, Rong Huang, Jingxin Shao, Rongbing Tang, Peng Wang, Yuexiao Jia, Xingyu Jiang*, et al. Composites of bacterial cellulose and small molecule-decorated gold nanoparticles for treating gram-negative bacteria-infected wounds. Small, 2017, 13, 1700130. (IF: 13.281)
代表性專利
[1] 蔣興宇，賈躍曉，一種基於納米晶纖維素的鉛離子檢測和去除方法，ZL201510046676.9。
[2] 蔣興宇，賈躍曉，一種基於納米晶纖維素檢測硫化氫氣體的方法，ZL201510046558.8。
[3] 蔣興宇，賈躍曉，一種多臂AIE分子在製備抗菌藥物中的用途和抗菌藥物，ZL201910506432.2。
[4] 蔣興宇，賈躍曉，一種多苯環共軛分子在製備抗病毒藥物中的用途及抗病毒藥物，ZL2021104058942。
